Chimeric mAbs were less evident ... this class of mAbs has been the main source of antibody-based products entering clinical studies since 1997. Figure 1: Number of mAbs entering clinical studies ...
News Medical on MSN14d
New CAR T-cell therapy shows promise against aggressive HER2+ breast cancerOne-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
How do antibody engineers select isotypes? IgG1 has been the most popular choice by far and was used for 13 approved chimeric, humanized or fully human antibodies (compared with only two instances ...
Vyloy is a chimeric IgG1 monoclonal antibody that binds to CLDN18.2 on the cancer cell surface of gastric epithelial cells. This action results in antibody-dependent cellular cytotoxicity and ...
Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR ... on cancer cells using an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback